← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity

SLGL logoSol-Gel Technologies Ltd.(SLGL)Earnings, Financials & Key Ratios

SLGL•NASDAQ
$71.40
$199M mkt cap·Price updated May 6, 2026
SectorHealthcareIndustryBiotechnologySub-IndustryCommercial Specialty Pharma
AboutSol-Gel Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on developing and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel. The company's lead product candidates include Twyneo, a novel, once-daily, non-antibiotic topical cream which has completed Phase III clinical trials for the treatment of acne vulgaris; Epsolay, a once-daily topical cream that has completed Phase III clinical trials for the treatment of papulopustular rosacea; SGT-210, which is in Phase I clinical trial for the treatment of palmoplantar keratoderma; and Erlotinib, Tapinarof, and roflumilast to treat psoriasis and other medical conditions. It is also involved in the development of generic topical dermatological drug products. The company has collaboration with Perrigo. Sol-Gel Technologies Ltd. was incorporated in 1997 and is headquartered in Ness Ziona, Israel.Show more
  • Revenue$19M+68.0%
  • EBITDA-$7M+36.5%
  • Net Income-$6M+42.1%
  • EPS (Diluted)-2.20-478.9%
  • Gross Margin99.44%+1.5%
  • EBITDA Margin-38.6%+62.2%
  • Operating Margin-39.16%+62.4%
  • Net Margin-31.6%+65.5%
  • ROE-23.72%+24.3%
  • ROIC-48.59%-17.2%
  • Debt/Equity0.04-4.2%
Technical→

SLGL Key Insights

Sol-Gel Technologies Ltd. (SLGL) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓Company is almost debt free
  • ✓Strong Piotroski F-Score: 7/9
  • ✓Momentum leader: RS Rating 93 (top 7%)
  • ✓Strong 5Y sales CAGR of 17.2%
  • ✓Share count reduced 90.0% through buybacks

✗Weaknesses

No significant weaknesses identified

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

SLGL Price & Volume

Sol-Gel Technologies Ltd. (SLGL) stock price & volume — 10-year historical chart

Loading chart...

SLGL Growth Metrics

Sol-Gel Technologies Ltd. (SLGL) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-
5 Years17.19%
3 Years70.92%
TTM282.9%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM66.87%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM70.22%

Return on Capital

10 Years-156.44%
5 Years-31.65%
3 Years-43.79%
Last Year-27.96%

SLGL Recent Earnings

Sol-Gel Technologies Ltd. (SLGL) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 5/12 qtrs (42%)●Beat Revenue 4/12 qtrs (33%)
Q2 2026Latest
Mar 19, 2026
EPS
$1.07
Est $0.39
-374.4%
Revenue
$7M
Est $7M
+0.0%
Q2 2026
Mar 11, 2026
EPS
$0.39
Est $0.39
+0.0%
Revenue
$7M
Est $7M
+0.0%
Q4 2025
Nov 20, 2025
EPS
$2.13
Est $2.09
-1.9%
Revenue
$400,000
Est $7M
-93.8%
Q3 2025
Aug 15, 2025
EPS
$4.17
Est $0.67
+722.4%
Revenue
$17M
Est $3M
+504.0%
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMar 19, 2026
$1.07vs $0.39-374.4%
$7Mvs $7M+0.0%
Q2 2026Mar 11, 2026
$0.39vs $0.39+0.0%
$7Mvs $7M+0.0%
Q4 2025Nov 20, 2025
$2.13vs $2.09-1.9%
$400,000vs $7M-93.8%
Q3 2025Aug 15, 2025
$4.17vs $0.67+722.4%
$17Mvs $3M+504.0%
Based on last 12 quarters of dataView full earnings history →

SLGL Peer Comparison

Sol-Gel Technologies Ltd. (SLGL) competitors in Commercial Specialty Pharma — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
DERM logoDERMJourney Medical CorporationDirect Competitor106.45M5.21-7.24-29.11%-15.49%-45.4%1.28
PRGO logoPRGOPerrigo Company plcDirect Competitor1.69B12.26-1.19-2.75%-43.5%-50.65%1.35
VYNE logoVYNEVYNE Therapeutics Inc.Direct Competitor28.64M0.67-1.0813.77%-46.46%-74.15%
SKIN logoSKINThe Beauty Health CompanyDirect Competitor120.86M0.93-5.83-10.02%-3.16%-15.42%6.20
GDRX logoGDRXGoodRx Holdings, Inc.Product Competitor880.73M2.5730.130.57%3.74%4.75%0.10
NKTR logoNKTRNektar TherapeuticsProduct Competitor1.67B85.09-8.75-43.89%-192.87%-356.81%0.95
PODD logoPODDInsulet CorporationProduct Competitor10.61B151.1743.4430.73%10.44%21.38%0.69
PAHC logoPAHCPhibro Animal Health CorporationSupply Chain2.38B58.6449.2827.37%6.29%30.81%2.67

Compare SLGL vs Peers

Sol-Gel Technologies Ltd. (SLGL) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs DERM

Most directly comparable listed peer for SLGL.

Scale Benchmark

vs PODD

Larger-name benchmark to compare SLGL against a more recognizable public peer.

Peer Set

Compare Top 5

vs DERM, PRGO, VYNE, SKIN

SLGL Income Statement

Sol-Gel Technologies Ltd. (SLGL) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
Line itemDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Sales/Revenue174K129K22.9M8.77M31.27M3.88M1.55M11.54M19.39M6.56M
Revenue Growth %--25.86%17655.04%-61.71%256.54%-87.58%-59.98%642.47%68.04%282.9%
Cost of Goods Sold300K28.15M40.58M27.91M20.38M12.68M342K233K109K16.63M
COGS % of Revenue172.41%21818.6%177.17%318.24%65.17%326.6%22.01%2.02%0.56%-
Gross Profit
-126K▲ 0%
-28.02M▼ 22135.7%
-17.67M▲ 36.9%
-19.14M▼ 8.3%
10.89M▲ 156.9%
-8.8M▼ 180.8%
-21.99M▼ 149.9%
11.3M▲ 151.4%
19.28M▲ 70.5%
-10.07M▲ 0%
Gross Margin %-72.41%-21718.6%-77.17%-218.24%34.83%-226.6%-1414.86%97.98%99.44%-153.48%
Gross Profit Growth %64.9%-22135.71%36.92%-8.31%156.9%-180.79%-149.88%151.42%70.54%-
Operating Expenses31.81M33.65M48.85M11.09M7.93M7.45M7.32M23.32M26.87M421K
OpEx % of Revenue18279.89%26085.27%213.3%126.45%25.35%191.73%470.91%202.11%138.6%-
Selling, General & Admin6M5.5M8.28M11.09M8.45M7.45M7.37M5.75M4.18M6.79M
SG&A % of Revenue3449.43%4266.67%36.13%126.45%27.02%191.73%474.45%49.83%21.54%-
Research & Development25.8M28.15M40.58M27.91M20.38M12.68M23.54M17.8M22.7M16.63M
R&D % of Revenue14830.46%21818.6%177.17%318.24%65.17%326.6%1514.86%154.3%117.06%-
Other Operating Expenses000-27.91M-20.91M-12.68M-23.6M-233K0-2M
Operating Income
-31.63M▲ 0%
-33.52M▼ 6.0%
25.95M▲ 177.4%
-30.23M▼ 216.5%
2.96M▲ 109.8%
-16.24M▼ 648.0%
-29.3M▼ 80.4%
-12.01M▲ 59.0%
-7.59M▲ 36.8%
-16.8M▲ 0%
Operating Margin %-18179.89%-25985.27%113.3%-344.69%9.48%-418.34%-1885.78%-104.13%-39.16%-256.17%
Operating Income Growth %-52.4%-5.97%177.41%-216.5%109.8%-648.04%-80.41%59%36.81%-
EBITDA-31.33M-32.76M26.84M-29.29M3.84M-15.68M-28.96M-11.78M-7.48M-16.43M
EBITDA Margin %-18007.47%-25394.57%117.17%-333.91%12.29%-403.86%-1863.77%-102.11%-38.6%-250.46%
EBITDA Growth %-53.62%-4.55%181.92%-209.13%113.13%-507.96%-84.69%59.32%36.48%-218.46%
D&A (Non-Cash Add-back)300K762K887K946K880K562K342K233K109K374K
EBIT-31.63M-33.52M-25.95M-30.23M2.96M-16.24M-29.3M-10.58M-7.59M-16.8M
Net Interest Income65K1.32M1.37M943K257K1.32M2.07M1.43M1.41M1.89M
Interest Income65K1.32M1.37M943K257K1.32M2.07M1.43M1.41M1.89M
Interest Expense0000000000
Other Income/Expense65K1.32M1.37M943K257K1.32M2.07M1.43M1.47M1.89M
Pretax Income
-31.57M▲ 0%
-32.2M▼ 2.0%
-24.58M▲ 23.7%
-29.29M▼ 19.2%
3.22M▲ 111.0%
-14.92M▼ 563.3%
-27.24M▼ 82.5%
-10.58M▲ 61.2%
-6.13M▲ 42.1%
-14.91M▲ 0%
Pretax Margin %-18142.53%-24963.57%-107.3%-333.94%10.3%-384.32%-1752.77%-91.7%-31.6%-227.4%
Income Tax-65K033K0000000
Effective Tax Rate %0.21%0%-0.13%0%0%0%0%0%0%0%
Net Income
-31.57M▲ 0%
-32.2M▼ 2.0%
-24.61M▲ 23.6%
-29.29M▼ 19.0%
3.22M▲ 111.0%
-14.92M▼ 563.3%
-27.24M▼ 82.5%
-10.58M▲ 61.2%
-6.13M▲ 42.1%
-14.91M▲ 0%
Net Margin %-18142.53%-24963.57%-107.44%-333.94%10.3%-384.32%-1752.77%-91.7%-31.6%-227.4%
Net Income Growth %-51.98%-2.01%23.58%-19.02%111%-563.3%-82.52%61.16%42.09%66.87%
Net Income (Continuing)-31.57M-32.2M-24.61M-29.29M3.22M-14.92M-27.24M-10.58M-6.13M-14.91M
Discontinued Operations0000000000
Minority Interest0000000000
EPS (Diluted)
-1.76▲ 0%
-1.80▼ 2.3%
-1.26▲ 30.0%
-1.30▼ 3.2%
0.14▲ 110.8%
-0.65▼ 564.3%
-1.01▼ 55.4%
-0.38▲ 62.4%
-2.20▼ 478.9%
-0.54▲ 0%
EPS Growth %0.56%-2.27%30%-3.17%110.77%-564.29%-55.38%62.38%-478.95%70.22%
EPS (Basic)-1.76-1.80-1.26-1.301.40-0.65-1.01-0.38-2.20-
Diluted Shares Outstanding17.99M17.87M19.53M22.57M23.57M23.13M27.09M27.86M2.79M27.86M
Basic Shares Outstanding17.99M17.87M19.53M22.57M23.06M23.13M27.09M27.86M2.79M27.86M
Dividend Payout Ratio----------

SLGL Balance Sheet

Sol-Gel Technologies Ltd. (SLGL) balance sheet — assets, liabilities & shareholders' equity

Line itemDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Total Current Assets10.55M65.97M55.79M53.4M57.11M43.05M41.17M31.3M26.97M38.28M
Cash & Short-Term Investments9.02M62.99M50.38M50.17M43.24M33.63M38M23.93M24M30.47M
Cash Only5.02M5.33M9.41M7.12M20.09M12.45M7.51M19.49M11.03M11.55M
Short-Term Investments4M57.66M40.97M43.05M23.16M21.18M30.48M4.44M12.97M18.92M
Accounts Receivable004.12M2.15M13.06M7.92M377K3.6M1.97M6.06M
Days Sales Outstanding--65.6689.6152.49744.4888.55113.7337.05101.63
Inventory0000000000
Days Inventory Outstanding----------
Other Current Assets0000002.79M3.77M1M1.75M
Total Non-Current Assets4.77M3.71M5.51M5.76M12.08M3.57M4.12M4.55M2.95M3.72M
Property, Plant & Equipment2.31M2.6M4.35M3.71M2.55M1.54M2.15M1.63M1.17M1.81M
Fixed Asset Turnover0.08x0.05x5.26x2.36x12.25x2.53x0.72x7.09x16.61x3.14x
Goodwill0000000000
Intangible Assets0000000000
Long-Term Investments1.77M0472K08.7M1.29M1.28M2.31M1.32M5.11M
Other Non-Current Assets680K1.1M684K2.05M830K749K681K608K455K2.66M
Total Assets
15.31M▲ 0%
69.68M▲ 355.0%
61.3M▼ 12.0%
59.16M▼ 3.5%
69.19M▲ 17.0%
46.63M▼ 32.6%
45.29M▼ 2.9%
35.85M▼ 20.8%
29.92M▼ 16.5%
42.01M▲ 0%
Asset Turnover0.01x0.00x0.37x0.15x0.45x0.08x0.03x0.32x0.65x0.15x
Asset Growth %39.42%354.99%-12.03%-3.49%16.95%-32.61%-2.88%-20.85%-16.54%-48.05%
Total Current Liabilities67.2M4.89M6.5M5.96M11.69M3.33M4.52M5.29M6.17M5.2M
Accounts Payable534K2.92M1.71M1.2M766K251K154K1.26M735K679K
Days Payables Outstanding649.737.9215.3815.7313.727.22164.361.98K2.46K9.05
Short-Term Debt65.34M0000000495K0
Deferred Revenue (Current)0000000000
Other Current Liabilities000000004.49M0
Current Ratio0.16x13.48x8.58x8.95x4.88x12.93x9.10x5.92x4.37x4.37x
Quick Ratio0.16x13.48x8.58x8.95x4.88x12.93x9.10x5.92x4.37x4.37x
Cash Conversion Cycle---------92.58
Total Non-Current Liabilities810K878K2.33M2.35M1.9M1.09M2.12M1.71M935K1.9M
Long-Term Debt0000000000
Capital Lease Obligations001.37M1.3M810K54K1.21M878K496K4.58M
Deferred Tax Liabilities0000000000
Other Non-Current Liabilities810K878K958K1.05M1.09M1.03M915K833K439K3.71M
Total Liabilities68.01M5.77M8.84M8.31M13.6M4.42M6.64M7M7.11M7.1M
Total Debt65.34M02.04M1.97M1.59M772K1.65M1.31M991K1.39M
Net Debt60.31M-5.33M-7.37M-5.15M-18.49M-11.68M-5.86M-18.18M-10.04M-10.15M
Debt / Equity--0.04x0.04x0.03x0.02x0.04x0.05x0.04x0.04x
Debt / EBITDA--0.08x-0.41x-----0.08x
Net Debt / EBITDA---0.27x--4.81x----0.62x
Interest Coverage----------
Total Equity
-52.7M▲ 0%
63.91M▲ 221.3%
52.47M▼ 17.9%
50.85M▼ 3.1%
55.59M▲ 9.3%
42.21M▼ 24.1%
38.64M▼ 8.5%
28.85M▼ 25.3%
22.81M▼ 20.9%
34.9M▲ 0%
Equity Growth %-68.17%221.27%-17.91%-3.08%9.33%-24.07%-8.45%-25.34%-20.93%-71.24%
Book Value per Share-2.933.582.692.252.361.831.431.048.191.25
Total Shareholders' Equity-52.7M63.91M52.47M50.85M55.59M42.21M38.64M28.85M22.81M34.9M
Common Stock82K520K561K635K638K638K774K774K774K774K
Retained Earnings-95.26M-127.46M-152.07M-181.36M-178.14M-193.06M-220.3M-230.88M-237.01M-224.67M
Treasury Stock0000000000
Accumulated OCI-1.98M000000000
Minority Interest0000000000

SLGL Cash Flow Statement

Sol-Gel Technologies Ltd. (SLGL) cash flow — operating, investing & free cash flow history

Line itemDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Cash from Operations-24.09M-23.47M-22.5M-25.24M-7.69M-9.48M-17.73M-13.89M322K322K
Operating CF Margin %-13844.25%-18191.47%-98.24%-287.78%-24.59%-244.24%-1140.93%-120.38%1.66%-
Operating CF Growth %-30.25%2.58%4.12%-12.18%69.53%-23.31%-86.95%21.66%102.32%0%
Net Income-31.57M-32.2M-24.61M-29.29M3.22M-14.92M-27.24M-10.58M-6.13M-14.91M
Depreciation & Amortization471K762K887K946K880K562K342K233K109K0
Stock-Based Compensation3.97M4.65M2.55M1.22M687K1.53M1.86M786K02.13M
Deferred Taxes029K65K138K-96K00000
Other Non-Cash Items6.18M-5K50K104K55K-188K-361K74K148K12.78M
Working Capital Changes-3.15M3.33M-1.45M1.64M-12.44M3.54M7.67M-4.4M6.19M0
Change in Receivables00-4.12M1.97M-18.31M12.55M7.54M-4.2M1.63M0
Change in Inventory001.69M0000000
Change in Payables-2.49M3.03M938K-542K5.62M-8.3M1.47M780K820K0
Cash from Investing-5.94M-54.73M16.02M-2.69M19.87M1.7M-9.74M26.69M-8.58M0
Capital Expenditures-1.93M-1.05M-597K-449K-143K-171K-134K-2K-47K0
CapEx % of Revenue1106.32%815.5%2.61%5.12%0.46%4.4%8.62%0.02%0.24%-
Acquisitions0000000054K0
Investments----------
Other Investing-4.01M8K-10K-21K-5K074K6K-20K0
Cash from Financing28M78.82M10.61M26.46M837K15K21.81M06K0
Debt Issued (Net)28M000000000
Equity Issued (Net)01000K1000K1000K505K15K1000K06K0
Dividends Paid0000000000
Share Repurchases0000000000
Other Financing044K0151K332K0268K000
Net Change in Cash
-1.98M▲ 0%
651K▲ 132.9%
4.09M▲ 527.8%
-1.49M▼ 136.5%
12.96M▲ 970.0%
-7.64M▼ 158.9%
-5.74M▲ 24.9%
12.8M▲ 323.2%
-8.46M▼ 166.1%
-8.11M▲ 0%
Free Cash Flow
-26.01M▲ 0%
-24.52M▲ 5.7%
-23.1M▲ 5.8%
-25.69M▼ 11.2%
-7.83M▲ 69.5%
-9.65M▼ 23.2%
-17.86M▼ 85.0%
-13.89M▲ 22.2%
275K▲ 102.0%
0▲ 0%
FCF Margin %-14950.57%-19006.98%-100.84%-292.9%-25.05%-248.65%-1149.55%-120.39%1.42%-
FCF Growth %-37.79%5.75%5.8%-11.23%69.51%-23.24%-85.02%22.24%101.98%-
FCF per Share-1.45-1.37-1.18-1.14-0.33-0.42-0.66-0.500.100.10
FCF Conversion (FCF/Net Income)0.76x0.73x0.91x0.86x-2.39x0.64x0.65x1.31x-0.05x-0.00x
Interest Paid0000000000
Taxes Paid0007K34K00000

SLGL Key Ratios

Sol-Gel Technologies Ltd. (SLGL) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric201720182019202020212022202320242025TTM
Return on Equity (ROE)--574.54%-42.29%-56.7%6.05%-30.52%-67.37%-31.35%-23.72%-39.95%
Return on Invested Capital (ROIC)-717.3%-75.96%37.54%-49.95%5.37%-36.02%-69.42%-41.47%-48.59%-48.59%
Gross Margin-72.41%-21718.6%-77.17%-218.24%34.83%-226.6%-1414.86%97.98%99.44%-153.48%
Net Margin-18142.53%-24963.57%-107.44%-333.94%10.3%-384.32%-1752.77%-91.7%-31.6%-227.4%
Debt / Equity--0.04x0.04x0.03x0.02x0.04x0.05x0.04x0.04x
FCF Conversion0.76x0.73x0.91x0.86x-2.39x0.64x0.65x1.31x-0.05x-0.00x
Revenue Growth--25.86%17655.04%-61.71%256.54%-87.58%-59.98%642.47%68.04%282.9%

SLGL Frequently Asked Questions

Sol-Gel Technologies Ltd. (SLGL) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Sol-Gel Technologies Ltd. (SLGL) reported $6.6M in revenue for fiscal year 2025.

Sol-Gel Technologies Ltd. (SLGL) grew revenue by 68.0% over the past year. This is strong growth.

Sol-Gel Technologies Ltd. (SLGL) reported a net loss of $14.9M for fiscal year 2025.

Dividend & Returns

Sol-Gel Technologies Ltd. (SLGL) has a return on equity (ROE) of -23.7%. Negative ROE indicates the company is unprofitable.

Sol-Gel Technologies Ltd. (SLGL) generated $0.3M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

Explore More SLGL

Sol-Gel Technologies Ltd. (SLGL) financial analysis — history, returns, DCA and operating performance tools

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.